Brief: Generation Bio Outlines 2023 Strategic Priorities And Reports Fourth Quarter And Full Year 2022 Financial Results
23/02/2023 23:41
Feb 23 (Reuters) - Generation Bio Co GBIO.O :
* GENERATION BIO OUTLINES 2023 STRATEGIC PRIORITIES AND
REPORTS
FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS
Source text for Eikon: ID:nGNXbJlHCx
Further company coverage: GBIO.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Generation Bio
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Nodthera Appoints Geoff Mcdonough, M.D., As Independent Board Member